Could vitamin c tame anemia? early trial tests high doses in rare blood disorders
NCT ID NCT07612345
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether high-dose Vitamin C is safe for people with two rare inherited blood disorders—Pyruvate Kinase Deficiency (PKD) and a form of G6PD deficiency. Both conditions cause red blood cells to break down too quickly, leading to anemia. The study will enroll 3 adults with PKD first, giving them Vitamin C up to three times daily for 3 weeks, while closely monitoring side effects and blood health. If safe, the trial may expand to include more patients and eventually children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLASS A GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Utah
Salt Lake City, Utah, 84112, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Promising new drug shows hope for rare anemia patients
- Gene therapy offers hope for rare blood disorder
- Blood cancer enzyme deficiency explored in new study
- New hope for rare blood disorder: Long-Term drug study shows promise
- Gene therapy offers hope for rare blood disorder
- Global registry launches to unlock secrets of rare blood disorder